Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
111
Frequently Asked Questions
What is Market Cap of Cullinan Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Cullinan Therapeutics Inc market cap is $424.74M.
What is the 52-week high for Cullinan Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cullinan Therapeutics Inc 52 week high is $17.50 as of November 09, 2025.
What is the 52-week low for Cullinan Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cullinan Therapeutics Inc 52 week low is $5.68 as of November 09, 2025.
What is Cullinan Therapeutics Inc stock price today?
Cullinan Therapeutics Inc stock price today is $7.19.
What was Cullinan Therapeutics Inc stock price yesterday?
Cullinan Therapeutics Inc stock price yesterday was $7.35.
What is the PE ratio of Cullinan Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Cullinan Therapeutics Inc’s P/E ratio is -1.95.
What is the Price-to-Book ratio of Cullinan Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Cullinan Therapeutics Inc P/B ratio is 0.9410.
What is the 50-day moving average of Cullinan Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Cullinan Therapeutics Inc 50-day moving average is $7.05.
How many employess does Cullinan Therapeutics Inc has?